UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025763
Receipt number R000028502
Scientific Title Randomized controlled trial evaluating the effect of new sternal fixation device for the patients who undergo open heart surgery
Date of disclosure of the study information 2017/02/24
Last modified on 2022/07/26 10:06:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial evaluating the effect of new sternal fixation device for the patients who undergo open heart surgery

Acronym

New sternal fixation device study

Scientific Title

Randomized controlled trial evaluating the effect of new sternal fixation device for the patients who undergo open heart surgery

Scientific Title:Acronym

New sternal fixation device study

Region

Japan


Condition

Condition

Patients who undergo cardiovascular surgery with full sternotomy

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the postoperative displacement of sternal halves with new sternal fixation device to that with simple wire cerclage

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Displacement of sternal halves (CT scan): 6 months after surgery

Key secondary outcomes

Displacement of sternal halves (CT scan): 2weeks and 3 months after surgery
Dihisecnce, Bone union, and CBDA; Cortical bone density area (CT scan): 2weeks, 3months, and 6months after surgery
Sternal infection and Pain score: 1week, 2weeks, 3weeks, 6weeks, 3months, and 6months after surgery
Quality of Life: 2weeks, 3weeks, 6weeks, 3months, and 6months after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Sternal closure with new sternal fixation device, which is inserted in bone marrow, followed by wire cerclage

Interventions/Control_2

Sternal closure with simple wire cerclage

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

20 years of age and more

Key exclusion criteria

Emergency, Diabetes (HbA1c is 8.0% and more), Hemodialysis, Steroid, Immunosuppressant, Severe COPD, Ventricular assist device, Infectious endocarditis, and Pacemaker lead infection

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Hirokuni
Middle name
Last name Arai

Organization

Tokyo Medical and Dental University

Division name

Department of Cardiovascular Surgery

Zip code

113-8519

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, JAPAN

TEL

03-5803-5267

Email

hiro.cvsg@tmd.ac.jp


Public contact

Name of contact person

1st name Kiyotoshi
Middle name
Last name Oishi

Organization

Tokyo Medical and Dental University

Division name

Department of Cardiovascular Surgery

Zip code

113-8519

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, JAPAN

TEL

03-5803-5270

Homepage URL


Email

oishi.cvsg@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical And Dental University, University Hospital of Medicine

Institute

Department

Personal name



Funding Source

Organization

Teijin Medical Technology Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical and Dental University Hospital of Medicine, Clinical Reserch Center

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JAPAN

Tel

03-5803-5612

Email

tiken.crc@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学医学部附属病院(東京都)
武蔵野赤十字病院(東京都)
青梅市立総合病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

70

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

under review

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 19 Day

Date of IRB

2016 Year 12 Month 15 Day

Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date

2021 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 20 Day

Last modified on

2022 Year 07 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028502


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name